Total body irradiation (TBI) is a part of a complex treatment program for aplastic anemia, leukemia, lymphoma and certain other cancers that require chemotherapy and bone marrow transplantation. TBI also helps to cause immunosuppression that is necessary to keep the recipient\'s immune system from rejecting the bone marrow transplant.\[[@CIT1][@CIT2]\] Hematologists, immunologists, radiotherapists and medical physicists have been trying to increase the success rate of TBI treatments. Improvement requires an understanding of all the clinical, biological and physical aspects.\[[@CIT3]\] There is no standard TBI technique as hospital radiotherapy departments adopt their own treatment plans that are influenced by the type of treatment facility available.\[[@CIT4]\] Therefore, different treatment distances, patient set-ups, radiation beams and radiation fields are used in different radiotherapy centers for TBI. Due to the variability of technique, it is not possible to use published data as a reference for another institute. Therefore, if a center wants to implement TBI, it has to measure the basic dosimetric parameters.\[[@CIT3][@CIT5]\]

In TBI set-ups, the patient represents a very irregular and extended field. When such treatment is used as part of the preparation for a bone marrow transplant, it is important to know the dose delivered throughout the body.\[[@CIT6][@CIT7]\] The determination of the dose delivered to the body during TBI is not easy, as direct measurements are impossible.\[[@CIT3]\] In this study, we present a simple method for absorbed dose determination in ^60^Co TBI using entrance and exit dose readings generated by the semiconductor detectors. The calibration of diodes is also presented here based on a previously described study.\[[@CIT8]\] The estimated accuracy in dose delivery in TBI as well as standard radiotherapy should be better than ±5%.\[[@CIT3]\]

Avoiding dose inhomogeneity is very important for TBI because it can lead to failure of TBI through either insufficient dose being delivered to the marrow stem cells or an excessive dose to the critical organs. Therefore, most techniques aim to achieve dose uniformity throughout the whole body while minimizing dose outside the volume especially to critical structures such as the lung.\[[@CIT9][@CIT10]\]

The purpose of this study were (i) to measure some basic dosimetric parameters in the TBI condition in order to check the accuracy in dose delivery. (ii) to develop an algorithm for dose calculation in TBI techniques, and (iii) to investigate dose uniformity in TBI treatment using a human phantom and semiconductor diodes.

Materials and Methods {#sec1-1}
=====================

The TBI technique was based on a set of parallel-opposed, anterior-posterior fields using a ^60^Co unit with the gantry rotated to project a horizontal beam. The beam collimator was set at 45° so that the field diagonal was projected onto the horizontal plane. The collimator was opened to its maximum field size of 35 × 35 at 80 cm from the source and the Source-Surface Distance (SSD) was 250 cm. The prescribed dose to the umbilicus was 13.5 Gy given in six fractions of 2.25 Gy each twice a day over three days.

Basic dosimetric parameters (PDD, SC, SP, DR) {#sec2-1}
---------------------------------------------

In order to calculate the required time for TBI treatment, the following equation was used:

$$\text{Time} = \left( \text{prescribed~dose} \right)/\left( {\text{Sc} \times \text{Sp} \times \text{PDD} \times \text{DR}} \right)$$

where the collimator scatter factor (SC) is defined as the ratio of the output in air for a given field to that for a reference field (10 × 10); the phantom scatter factor (SP) is defined as the ratio of the dose rate for a given field at a reference depth (depth of maximum dose) to the dose rate at the same depth for the reference field size (10 × 10) with the same collimator opening; percentage depth dose (PDD) is expressed as a percentage of absorbed dose at any depth to the absorbed dose at a fixed reference depth (depth of maximum dose) along the central axis of the beam and DR is defined as the output in the phantom for the reference field size (10 × 10) at the depth of the maximum dose.\[[@CIT1][@CIT5]\] SC, SP, PDD and dose rate (DR) were measured in this study.

Depth dose measurements {#sec2-2}
-----------------------

Depth dose measurements along the central beam axis were measured in a 30 × 30 × 30 cm^3^ water phantom at a 250-cm source-surface distance using a 0.6-cc Farmer chamber (TM30010, PTW Freiburg) and an electrometer (PTW-UNIDOS). The depth dose fall-off from 2.5 to 25 cm was measured. For surface dose measurements and for relative measurements in the build-up region, a parallel plate chamber (TM23343-PTW Freiburg) was used as previously described.\[[@CIT4]\] This chamber was put on the water phantom and variable thicknesses of a water-equivalent sheet (T40006, RW3 slab phantom-PTW Freiburg) were placed over the chamber before measurements were taken and corrected for the slight SSD variation.\[[@CIT11][@CIT12]\] A comparison of this depth dose data was made with the measured depth dose at 80 cm SSD and transformed using the Mayneord formula to the TBI distance (SSD = 250 cm).\[[@CIT1][@CIT4][@CIT11][@CIT12]\]

Scatter factors {#sec2-3}
---------------

The SC measurement for TBI (with settings: SSD = 250 cm, field size = 35 × 35, collimator angle = 45) was performed using the Farmer ion chamber (0.6 cc) with a cylindrical cap having a radius equal to the electron build-up depth for ^60^Co.\[[@CIT1][@CIT5]\] In order to measure the phantom scatter factor the following equation was used:

$$\text{Sp} = \frac{S_{c,p}}{S_{c}}$$

where in this equation, SC,P is the total scatter factor \[defined as the dose rate at a reference depth for a given field size divided by the dose rate at the same point and depth to the reference field size (10 × 10)\]. SC,P was acquired from measurements made in the build-up region. The irradiation was based on the calculated time through measurement data and prescribed dose to the umbilicus. In order to check the accuracy in dose delivery, a human phantom which had three sections (head and neck, trunk, hip) was used.\[[@CIT13]\] A 0.3-cc ion chamber (TM31013, PTW-Freiburg) was imbedded in the phantom at the prescribed point (umbilicus) and the delivered dose was measured.

Effect of phantom (patient) length {#sec2-4}
----------------------------------

The dose absorbed at any given point depends on the scattering volume surrounding the point.\[[@CIT4][@CIT12]\] Measurements were made to determine the effect of patient length on absorbed dose. The central axis of the water phantom was monitored at several depths while the longitudinal extent of the phantom was changed. Initial measurements started with a 30 × 30 × 30 cm^3^ water phantom and additional material of slab phantoms was added to one side.

Midplane dose determination Calibration technique {#sec2-5}
-------------------------------------------------

For obtaining the entrance and exit measurements of the human phantom, four p-type diodes (T60010L) were used as dosimeters connected to a MULTIDOS electrometer (T10004). For entrance measurements, calibration diodes were taped on the 30 × 30 × 30 cm^3^ water phantom at an SSD of 250 cm with a 35 × 35 field size. The calibration of these diodes was performed against the 0.6 cc Farmer chamber at depth of 0.5 cm connected to a UNIDOS electrometer (T10001).

The calibration factor (F) was then determined as the ratio of the absorbed dose measured with the Farmer chamber (D) to the reading of the diode (M) in TBI experimental conditions. The exit calibration was the same as the entrance calibration with the exception that the water phantom was turned at 180°.

$$\text{F} = \frac{D}{M}$$

Target dose calculation {#sec2-6}
-----------------------

Using combined entrance and exit dose measurements (D~en~, D~ex~), one can estimate the dose delivered to a point placed in the target volume (midplane at umbilicus). In our center, the midplane dose was estimated by three different algorithms: The first algorithm is the arithmetical mean of the entrance and the exit doses. The second algorithm is the geometric means of the entrance and the exit doses.\[[@CIT3]\] The conversion of entrance and exit doses to any other point is performed using the percentage depth dose corresponding to that point. For example, to obtain D~mid~ from the entrance dose (D~en~), we can multiply D~en~ by PDD~mid~ and to obtain D~mid~ from the exit dose (D~ex~), we can multiply D~ex~ by the ratio of PDD~mid~/PDD~ex~ as shown below:

$$\frac{\text{PDD}_{\text{mid}}}{\text{PDD}_{\text{ex}}} = \frac{\frac{\text{D}_{\text{mid}}}{\text{D}_{\text{en}}}}{\frac{\text{D}_{\text{ex}}}{\text{D}_{\text{en}}}} = \frac{\text{D}_{\text{mid}}}{\text{D}_{\text{ex}}}$$

$$\text{D}_{\text{ex}}\text{=}\frac{\text{PDD}_{\text{mid}}}{\text{PDD}_{\text{ex}}}\text{=D}_{\text{mid}}$$

$$\text{D}_{\text{en}} \times \text{PDD}_{\text{mid}} = \text{D}_{\text{en}} \times \frac{\text{D}_{\text{mid}}}{\text{D}_{\text{en}}} = \text{D}_{\text{mid}}$$

To reduce the statistical error in the measurements, the average of Eqs. [(5)](#FD5){ref-type="disp-formula"} and [(6)](#FD6){ref-type="disp-formula"} was calculated and the third algorithm was expressed as:

$$\text{D}_{\text{mid}} = \frac{\text{D}_{\text{en}} \times \text{PDD}_{\text{mid}} + \text{D}_{\text{ex}} \times \frac{\text{PDD}_{\text{mid}}}{\text{PDD}_{\text{ex}}}}{2}$$

where PDD corresponds to the percentage depth dose measured in TBI experimental conditions and D~en~ and D~ex~ are entrance and exit doses respectively. The validity of these algorithms was investigated using the human phantom.\[[@CIT13]\] Surface doses were measured by diodes and the positioning of these detectors was carefully carried out in order to avoid a shadowing effect. Midplane doses were measured with the 0.3 cc ionization chamber (TM31013).

Dose uniformity {#sec2-7}
---------------

The human phantom was used to investigate dose uniformity throughout the whole body. Diodes were taped on the anterior and posterior surfaces of the human phantom (at six points) and AP/PA radiation was given \[[Figure 1](#F0001){ref-type="fig"}\]. Measured doses at different sites were compared to that at the umbilicus.\[[@CIT10]\] The delivered dose to the mid-lobe of the lung was also measured with the ionization chamber (0.3 cc). In order to reduce the lung dose, a proper Cerrobend shield (1.14 cm thickness) was built.

![Anterior feature of the human phantom with the diodes](JMP-32-169-g001){#F0001}

Lung shield {#sec2-8}
-----------

A mobile X-ray set placed at the position of ^60^Co was used to take AP and PA films covering the thoracic region of the human phantom based on TBI experimental conditions described. The films used to design the lung shield made from Cerrobend. To simplify planning and treatment, the AP and PA films were overlaid by the physicist and a combined outline was used to define the outline shield.\[[@CIT14][@CIT15]\] Additionally, in order to maintain the lung shield, a TBI stand consisting of 11 steel pieces with dimensions of 70 × 100 × 210 cm^3^ was built, which appears to be also useful for patient support \[[Figure 2](#F0002){ref-type="fig"}\].

![TBI stand with the lung shields](JMP-32-169-g002){#F0002}

Results {#sec1-2}
=======

The central axis depth dose data for ^60^Co for different field sizes (5 × 5 to 35 × 35 cm) at TBI treatment distance (250 cm SSD) are shown in [Table 1](#T0001){ref-type="table"}. The results of depth dose data measured at 100 cm SSD and transformed using the Mayneord formula to the TBI distance are also shown in [Table 1](#T0001){ref-type="table"}. The data transformed using the Mayneord formula is about 8% lower than the measured data for most of the distance at 2 to 25 cm depth. The mean differences between the calculated and measured percentage depth doses were 3.09% with a standard deviation of 2.51%, whereas in the large field used in treatments of TBI (35 × 35), this difference was 0.71% with a standard deviation of 0.96%.

###### 

Measured and calculated percentage depth dose (using the Mayneord formula) at total body irradiation distance (SSD = 250 cm)

  *Field size Depth (cm)*   *5 × 5*   *10 × 10*   *15 × 15*   *20 × 20*   *25 × 25*   *30 × 30*   *35 × 35*
  ------------------------- --------- ----------- ----------- ----------- ----------- ----------- -----------
  2.5 mea                   94.92     96.48       96.59       97          98.15       98.80       98.90
  cal                       92.82     94.27       94.89       95.30       95.51       95.72       95.82
  4 mea                     89.55     91.92       92.24       92.50       93.65       94.14       94.29
  cal                       85.38     88.55       89.82       90.56       90.98       91.30       91.51
  5 mea                     85.70     88.41       88.90       89.20       89.23       89.71       89.84
  cal                       80.90     84.78       86.39       87.47       87.90       88.33       88.65
  6.5 mea                   80.05     83.57       84.01       84.22       84.27       84.81       84.88
  cal                       73.97     78.81       81.12       82.28       83.00       83.66       84.04
  7.5 mea                   76.19     80.17       80.61       80.95       81.96       82.51       82.59
  cal                       69.65     74.91       77.48       78.93       79.83       80.50       80.95
  8 mea                     74.26     78.38       78.92       79.14       79.24       79.61       79.78
  cal                       67.42     72.85       75.55       77.24       78.25       78.93       79.38
  9 mea                     70.53     75.17       75.79       76.05       76.13       76.63       76.81
  cal                       64.43     69.15       72.00       73.83       74.98       75.78       76.35
  10 mea                    67.43     72.01       72.71       72.97       72.99       73.47       73.52
  cal                       59.40     65.43       68.68       70.54       71.81       72.62       73.32
  11 mea                    63.39     68.38       69.09       69.42       69.51       70.85       70.95
  cal                       55.78     61.79       65.08       67.32       68.61       69.56       70.38
  12 mea                    60.41     65.64       66.28       66.65       66.67       67.09       68.10
  cal                       52.25     58.33       61.91       64.06       65.61       66.56       67.40
  13 mea                    56.62     62.00       62.81       63.22       63.27       64.00       64.70
  cal                       48.91     55.17       58.8        61.10       62.67       63.88       64.61
  14 mea                    54.14     59.84       60.56       60.87       60.95       61.35       62.01
  cal                       45.78     52.04       55.72       58.18       59.77       61.12       61.98
  15 mea                    50.81     56.61       57.38       57.77       58.20       59.09       59.35
  cal                       42.93     49.02       52.88       55.37       57.11       58.36       59.23
  18 mea                    43.21     49.18       50.03       50.42       50.49       50.86       51.64
  cal                       35.32     41.01       44.90       47.48       49.30       50.72       51.63
  20 mea                    38.47     40.89       45.36       45.74       46.03       46.35       47.16
  cal                       30.81     36.39       40.11       42.77       44.49       46.09       47.15
  22 mea                    34.15     39.67       40.69       41.03       41.26       41.80       42.72
  cal                       26.99     32.14       35.94       38.52       40.42       41.77       42.72
  25 mea                    28.50     33.62       34.70       35.17       35.45       36.49       37.41
  cal                       22.23     27.03       30.65       33.03       34.86       36.35       37.40

The depth dose fall-off from 2.5 to 25 cm depth for a 35 × 35 cm field size is shown in [Figure 3](#F0003){ref-type="fig"}.

![Depth dose fall-off](JMP-32-169-g003){#F0003}

The surface dose and the central axis depth dose in the build-up region for TBI treatment distance are shown in [Figure 4](#F0004){ref-type="fig"}. The results show a plateau at 5 mm and a relative surface dose of 84%.

![Build-up dose based on the TBI experimental conditions](JMP-32-169-g004){#F0004}

The measured dose at the umbilicus based on SC and SP ([Eq. 2](#FD2){ref-type="disp-formula"}) was 2.31 Gy. From this measurement, the accuracy in dose delivery at the prescribed point (umbilicus) was found to be 2.59%. Results presented in [Table 2](#T0002){ref-type="table"} show the effect of the doses measured at 0.5, 5 and 10 cm as a result of increasing scattering volume added in the phantom (patient) length direction. It shows that the increased scattering volume reaches a plateau at a depth of around 51 cm.

###### 

The effect of adding scattering materials on the absorbed dose

  *Thickness of scattering material*   *Absorbed dose (mGy) At depth of 0.5 cm*   *Absorbed dose (mGy) At depth of 5 cm*   *Absorbed dose (mGy) At depth of 10 cm*
  ------------------------------------ ------------------------------------------ ---------------------------------------- -----------------------------------------
  0                                    119.928                                    105.002                                  86.318
  3                                    120.063                                    105.378                                  86.759
  6                                    120.167                                    105.602                                  87.102
  9                                    120.302                                    105.853                                  87.291
  12                                   120.404                                    105.952                                  87.354
  15                                   120.507                                    106.078                                  87.543
  18                                   120.507                                    106.078                                  87.543
  21                                   120.507                                    106.239                                  87.543
  24                                   120.507                                    106.239                                  87.543
  27                                   120.507                                    106.239                                  87.543

The ratios of the measured to the calculated midplane doses based on the three algorithms are summarized in [Table 3](#T0003){ref-type="table"}. The accuracy in the arithmetical mean algorithm was above 10%. The accuracy in the geometrical mean algorithm was within 4% and it was within 3.5% in our proposed algorithm. The mean difference between the calculated and measured doses in the first algorithm was 0.94 with a standard deviation of 0.61%; in the second algorithm, it was 2.82 with a standard deviation of 1.76% and in the third algorithm, it was 0.82 with a standard deviation of 0.54%.

###### 

The ratios of measured to the calculated midplane doses based on the three algorithms

  *Calculation method*          $\frac{\text{D}_{\text{mea}}}{\text{D}_{\text{cal}}} \pm \text{SD}$
  ----------------------------- ---------------------------------------------------------------------
  Arithmetical mean algorithm   1.038 ± 0.002
  Geomentrical mean algorithm   1.125 ± 0.003
  Proposed algorithm            1.033 ± 0.002

Point dose measurements at anterior and posterior of human phantom are summarized in [Table 4](#T0004){ref-type="table"}. These results show that dose uniformity at the anterior surface was within 6% and it was within 5% at the posterior surface. The delivered dose to the mid-lobe of the lung with and without the shield is presented in [Table 5](#T0005){ref-type="table"}. It has been seen that the delivered lung dose without the shield was 14.14 Gy but by applying a proper shield (1.14 cm thickness), it has been reduced to 8.16 Gy.

###### 

Point dose measurements at anterior and posterior surfaces of the human phantom

  *Site*                *Anterior dose (cGy)*   *Posterior dose (cGy)*
  --------------------- ----------------------- ------------------------
  Umbilicus             235.340                 239.104
  Hip                   248.238                 237.813
  Epigastria            243.916                 234.170
  Supra sternal notch   236.996                 243.037
  Lip                   230.127                 250.466
  Neck                  236.900                 238.040

###### 

Delivered lung dose with and without the shield

  *Lung dose*            *AP*      *PA*      *AP + PA 1 fraction*   *AP + PA 6 fractions*
  ---------------------- --------- --------- ---------------------- -----------------------
  Without shield (cGy)   105.800   129.850   235.650                1414
  with shield (cGy)      60.990    75.070    136.060                816

Discussion {#sec1-3}
==========

The results in [Table 1](#T0001){ref-type="table"} illustrate a poor coincidence between the calculated and measured percent depth doses for small and intermediate fields. But as the collimator opening was comparable with the mean range of scattered photons, the scatter contribution to the dose reached its maximum. Hence, the calculated percent depth dose using the Mayneord formula which does not account for a change in the scatter component showed increasing agreement with the measured data. However, for the largest field, deviation is minimum and there is no significant difference between them. It can be suggested that, for the simplicity, the calculated percentage depth dose be used instead of the measured percentage depth dose. The result in [Figure 3](#F0003){ref-type="fig"} demonstrates that the depth dose fall-off from 2.5 to 25 cm is nearly linear. Hence, a combined parallel opposed irradiation produces dose uniformity across a homogeneous transverse section of the patient.

The results of the build-up dose are shown in [Figure 4](#F0004){ref-type="fig"}. Skin sparing is undesirable for some treatment situations. For example, an adequate skin dose must be maintained for patients who have a generalized disease such as leukemia, where leukemia blast cells can be presumed to be circulating in the capillary bed immediately beneath the skin surface. Another example is neuroblastoma. This tumor is distributed widely throughout the body and in superficial bones lying less than 1 cm beneath the surface.\[[@CIT2]\] Therefore, the skin dose should be high in neuroblastomas as well. As shown in [Figure 4](#F0004){ref-type="fig"}, the skin dose is 84%, which is one of the advantages of using ^60^Co to an accelerator option in the TBI treatment, as the skin dose may be smaller with high energy accelerators. As mentioned earlier, the results based on the measurements of basic dosimetric parameters confirmed that the measured dose to the umbilicus was within 3% of the prescribed dose to the umbilicus. The accuracy and variation of the dose delivered to the umbilicus is considered to be clinically acceptable.\[[@CIT1]\] The implication of the results in [Table 2](#T0002){ref-type="table"} is that adding scatter material around the phantom does not changes depth doses significantly and The effect of phantom (patient) length on absorbed dose effect would be canceled. It can be seen from [Table 3](#T0003){ref-type="table"} that using both calculation methods, proposed and arithmetical mean algorithms, the dose agrees with the measured dose within 4%. But the geometric mean algorithm has a larger error and is not acceptable. Among the three algorithms discussed earlier, the proposed algorithm appears to be more appropriate for the determination of the midplane dose from entrance and exit measurements in TBI treatment. The results in [Table 4](#T0004){ref-type="table"} show that the difference between doses in the whole body relative to the umbilicus is within ±7%, which is in agreement with the results obtained by Harden.\[[@CIT15]\] The delivered dose in some areas such as the neck is higher because of the combination of reduced beam intensity and a relative lack of scattered material in this area. The lung region shows an increased dose relative to the prescribed dose to the umbilicus due to its density. However, by applying a shield, it has been reduced to 8.16 Gy which is below the tolerance level.\[[@CIT14]\] The TBI stand made in this project has the capability of being extended for shields for organs other than the lungs, for example, the eyes of patients undergoing TBI treatment.

Conclusion {#sec1-4}
==========

Basic dosimetric parameters which are necessary in TBI treatment were measured in this study. The proposed algorithm by this work appears to be useful with an accuracy within 2.5%. Accuracy in dose delivery was within 3% and dose uniformity through the whole body was within ±7%.
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